Thursday, April 16, 2015
Recombinant Factor VIII Products
Tom M. Schaumberg
Adduci, Mastriani, & Schaumberg LLP
Baxter International Inc., Baxter Healthcare Corporation, and Baxter Healthcare SA.
Letter to Lisa R. Barton, Secretary, USITC; requesting that the Commission conduct an investigation under section 337 of the Tariff Act of 1930, as amended, regarding Certain Recombinant Factor VIII Products. The proposed respondents are Novo Nordisk A/S, Denmark and Novo Nordisk Inc., Plainsboro, New Jersey.